Zenas BioPharma Inc (ZBIO)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Quarter End | Sep 2024 | |
|---|---|---|
| USD ($) | USD ($) | |
| Total Assets | 403.43M | |
| Total Current Assets | 393.78M | |
| Cash and Equivalents | 360.04M | |
| Total Non-Current Assets | 9.65M | |
| Total Liabilities | 44M | |
| Total Current Liabilities | 44M | |
| Total Non-Current Liabilities | 0 | |
| Common Equity | 4k | |
| Retained Earnings | -334.79M |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Assets | 74.58M | 68.18M |
| Total Current Assets | 68.44M | 59.8M |
| Cash and Equivalents | 67.21M | 56.86M |
| Total Non-Current Assets | -192.29M | -225.72M |
| Total Liabilities | 26.78M | 43.82M |
| Total Current Liabilities | 25.97M | 23.26M |
| Total Non-Current Liabilities | 812k | 40.86M |
| Total Equity | -192.29M | -225.72M |
| Common Equity | 1,000 | 1,000 |
| Retained Earnings | -193.28M | -230.4M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
